Essex Bio-Technology Limited: Essex Biotechnology Secures Exclusive Global Rights and Interests of SkQ1 in the field Ophthalmology from Mitotech

HONG KONG, Oct 13, 2022 - (ACN Newswire) - Essex Bio-Technology Limited (the "Company", together with its subsidiaries, the "Group") wishes to announce that Essex Bio-Investment Limited ("Essex Bio-Investment")

Related Keywords

Kazakhstan ,Kyrgyzstan ,United States ,Armenia ,Belarus ,Luxembourg ,China ,Russia ,Shelly Cheng ,Essex Bio ,Jill Cheung ,Mitotech Sa ,Holly Szeto ,Development Agreement ,Technology Limited Stock Code ,Strategic Financial Relations Limited Website ,Investment Limited Essex Bio ,Technology Limited The Company ,Bio Technology Limited ,Essex Bio Investment Limited ,Essex Bio Investment ,Co Development Agreement ,Hereditary Optic Neuropathy ,Essex Bio Technology Limited ,Stock Code ,Iodized Lecithin Capsules ,Financial Relations Limited ,Essex Bio Technology ,Essex ,Technology ,Imited ,Biotechnology ,Ecures ,Exclusive ,Lobal ,Tights ,Interests ,Kq1 ,Field ,Ophthalmology ,Rom ,Itotech ,